Definitive Contract 75D30121C12111

The Pennsylvania State University (Penn State) was awarded a $1.23 million cost-no-fee contract by the Centers for Disease Control and Prevention (CDC) to conduct whole-genome sequencing of Bacilli isolates. Under the FY2021 Broad Agency Announcement Topic 3, Penn State will sequence the isolates using Oxford Nanopore Technologies' MinION MK1C sequencing devices and associated flow cells, barcoding kits, and priming kits provided by Oxford Nanopore Technologies Inc. as a major subcontractor. The work will be performed at Penn State University's location in Pennsylvania over a one-year period ending in August 2022. No set-aside designation was specified. The contract supports the CDC's efforts to advance public health through genomic surveillance and characterization of bacterial pathogens.